Published Date: 08 Mar 2023
A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...
Read Full NewsThe U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...
Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.
Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.
1.
WHO launches plan for free child cancer medicines
2.
Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.
3.
Waiting for a Sharp Increase in Prostate Cancer Cases.
4.
No increased risk of childhood cancer near UK nuclear sites, study finds
5.
Weight loss trial reports success for breast cancer patients at one year mark
1.
Symptoms and Causes of Phlegmasia Cerulea Dolens: A Comprehensive Guide
2.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
3.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
4.
Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring
5.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation